Arvinas logo

BRD4 Degraders Produce Long-Lasting Loss of BRD4 Protein and Robust Efficacy in Burkitt’s Lymphoma, Multiple Myeloma and Prostate Cancer Cells

Kevin Coleman, et al.

May 1, 2015
American Society of Clinical Oncology Annual Meeting
Skip to content